Trial Profile
Intra-articular infliximab versus methylprednisolone in patients with knee osteoarthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jun 2012
Price :
$35
*
At a glance
- Drugs Infliximab (Primary) ; Methylprednisolone
- Indications Osteoarthritis
- Focus Biomarker; Therapeutic Use
- 30 Jun 2012 New trial record
- 09 Jun 2012 Results presented at the 13th Annual Congress of the European League Against Rheumatism.